Exelon (EXC) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
6 May, 2026Executive summary
Adjusted operating earnings for Q1 2026 were $0.91 per share, slightly down from $0.92 in Q1 2025, with GAAP EPS steady at $0.90 per share; net income attributable to common shareholders rose $11 million year-over-year to $919 million.
2026 operating earnings guidance was reaffirmed at $2.81–$2.91 per share, with long-term growth targeted near the top end of the 5–7% range from 2025–2029.
All utilities maintained top quartile reliability, with ComEd in the top decile despite severe storms.
Strategic capital reallocation and project reprioritization are underway to balance affordability and long-term infrastructure needs.
Regulatory progress includes Maryland's Utility RELIEF Act and ongoing rate cases in Pepco MD and DPL DE.
Financial highlights
Q1 2026 operating revenues were $7.24 billion, up from $6.71 billion year-over-year; operating income was $1.61 billion, up from $1.54 billion.
Adjusted (non-GAAP) operating earnings for Q1 2026 were $930 million, compared to $932 million last year.
Cash flows from operating activities increased to $1.72 billion from $1.20 billion year-over-year.
Capital expenditures for Q1 2026 were $2.36 billion, up from $1.95 billion.
$1 billion in customer savings delivered over the past year through relief programs, settlements, and cost management.
Outlook and guidance
Full-year 2026 adjusted operating earnings guidance reaffirmed at $2.81–$2.91 per share, aiming for midpoint or better.
Projected $41.7 billion in capital expenditures over the next four years, supporting an expected rate base growth of 7.9%.
Annualized earnings growth targeted near the top end of 5–7% through 2029.
Transmission rate base projected to grow at 16% through 2029, with $12–$17 billion in additional opportunities.
PECO withdrew its 2026 rate case filings and will reassess timing for future capital investments.
Latest events from Exelon
- Shareholders approved all proposals as leadership outlined growth, affordability, and innovation plans.EXC
AGM 202628 Apr 2026 - 2025 adjusted EPS rose to $2.77; 2026 guidance targets 6%+ growth and $41.3B capital plan.EXC
Q4 202513 Apr 2026 - Proxy covers director elections, auditor ratification, say-on-pay, and major ESG progress.EXC
Proxy Filing18 Mar 2026 - Votes will be cast on board nominees, auditor ratification, and executive pay at the 2026 meeting.EXC
Proxy Filing18 Mar 2026 - Targeting 5-7% annual earnings growth and $41.3B in capital investment through 2029.EXC
Investor presentation16 Mar 2026 - Q2 2024 adjusted EPS up 15% year-over-year; guidance and long-term growth reaffirmed.EXC
Q2 20242 Feb 2026 - Q3 2024 adjusted EPS rose to $0.71, with robust cash flow and $34.5B in investments planned.EXC
Q3 202417 Jan 2026 - 2024 EPS hit $2.50, $38B capex plan set, and S&P credit rating upgraded to BBB+.EXC
Q4 20248 Jan 2026 - Q1 2025 Adjusted EPS up 35% year-over-year; full-year guidance and growth outlook reaffirmed.EXC
Q1 202525 Dec 2025